Song Zhiping (L-R), chairman of Sinopharm Group, Ronald Arculli, chairman of Hong Kong Exchanges & Clearing Ltd. and She Lulin, president of Sinopharm Group Co. Ltd., celebrate on the trading floor during the debut of Sinopharm Group Co. Ltd. at the Hong Kong Stock Exchange September 23, 2009. Shares of Sinopharm Group Co Ltd, China's top pharmaceutical products distributor, rose 23.4 percent in their Hong Kong debut on Wednesday, as investors bet on strong growth for China's healthcare sector. REUTERS/Bobby Yip (CHINA POLITICS BUSINESS HEALTH)
REUTERS/BOBBY YIP